The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Reversion of RAS mutations in metastatic colorectal cancer in the CCTG CO.26 clinical trial.
 
Florence T.H. Wu
Honoraria - Bristol-Myers Squibb
 
James T. Topham
No Relationships to Disclose
 
Christopher J. O'Callaghan
No Relationships to Disclose
 
Harriet Feilotter
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Diaceutics; EMD Serono; Janssen Diagnostics; Novartis Canada Pharmaceuticals Inc; Pfizer; Precision RxDx; Roche Canada
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen Diagnostics; Precision RxDx; Roche Canada
Speakers' Bureau - AstraZeneca; Bayer; EMD Serono
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Delphi Diagnostics (Inst); EMD Serono (Inst); EMD Serono (Inst); Lilly (Inst); Roche Canada (Inst)
 
Hagen Fritz Kennecke
Honoraria - Natera; Novartis; Tersera
Consulting or Advisory Role - Tersera
Speakers' Bureau - Natera
Research Funding - Exelixis (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst)
 
Kimberly Banks
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Guardant Health
 
Daniel John Renouf
Honoraria - Bayer; Roche
Consulting or Advisory Role - Roche
Research Funding - Bayer (Inst); Roche (Inst)
 
Derek J. Jonker
Consulting or Advisory Role - AstraZeneca
 
Dongsheng Tu
No Relationships to Disclose
 
Eric Xueyu Chen
Honoraria - AstraZeneca Canada; Bayer; Eisai; Ipsen
Research Funding - 1Globe Health Institute; AstraZeneca/MedImmune; Bristol-Myers Squibb; Merck Sharp & Dohme; Mirati Therapeutics; Novartis; Nubiyota; Repare Therapeutics; Roche Canada
 
Jonathan M. Loree
Consulting or Advisory Role - Advanced Accelerator Applications; AMGEN; Bayer; Ipsen; Pfizer; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Ipsen (Inst)